Patents by Inventor Bruce Levison

Bruce Levison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods, assays and kits for detecting exposure to cyanotoxins
    Patent number: 11125750
    Abstract: Methods and kits for the detection of toxic cyanobacteria in a sample by analyzing the sample for the presence antibodies raised in a host, where the presence of antibodies is indicative of toxic cyanobacteria, are described.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: September 21, 2021
    Assignee: The University of Toledo
    Inventors: David Kennedy, Steven Haller, R. Mark Wooten, Deepa Mukundan, Apurva Lad, John Presloid, Jason Huntley, Bruce Levison
  • Methods, Assays and Kits for Detecting Exposure to Cyanotoxins
    Publication number: 20200003775
    Abstract: Methods and kits for the detection of toxic cyanobacteria in a sample by analyzing the sample for the presence antibodies raised in a host, where the presence of antibodies is indicative of toxic cyanobacteria, are described.
    Type: Application
    Filed: June 27, 2019
    Publication date: January 2, 2020
    Applicant: The University of Toledo
    Inventors: David Kennedy, Steven Haller, R. Mark Wooten, Deepa Mukundan, Apurva Lad, John Presloid, Jason Huntley, Bruce Levison
  • Treatment and prevention of cardiovascular disease and thrombosis
    Patent number: 10064830
    Abstract: Provided herein are compositions for the treatment and/or prevention of cardiovascular disease (CVD), and methods of application and use thereof. In particular, the present invention provides treatment and/or prevention of cardiovascular disease with compounds that inhibit the production of TMA in the gut, such as 3,3-dimethyl-1-butanol (DMB) or other compounds represented by Formula I or as shown in FIGS. 20-23.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: September 4, 2018
    Inventors: Stanley L. Hazen, Bruce Levison, Zeneng Wang
  • TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE AND THROMBOSIS
    Publication number: 20170258740
    Abstract: Provided herein are compositions for the treatment and/or prevention of cardiovascular disease (CVD), and methods of application and use thereof. In particular, the present invention provides treatment and/or prevention of cardiovascular disease with compounds that inhibit the production of TMA in the gut, such as 3,3-dimethyl-1-butanol (DMB) or other compounds represented by Formula I or as shown in FIGS. 20-23.
    Type: Application
    Filed: May 25, 2017
    Publication date: September 14, 2017
    Inventors: Stanley L. Hazen, Bruce Levison, Zeneng Wang
  • TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE AND THROMBOSIS
    Publication number: 20160101062
    Abstract: Provided herein are compositions for the treatment and/or prevention of cardiovascular disease (CVD), and methods of application and use thereof. In particular, the present invention provides treatment and/or prevention of cardiovascular disease with compounds that inhibit the production of TMA in the gut, such as 3,3-dimethyl-1-butanol (DMB) or other compounds represented by Formula I or as shown in FIGS. 20-23.
    Type: Application
    Filed: October 26, 2015
    Publication date: April 14, 2016
    Inventors: Stanley L. Hazen, Bruce Levison, Zeneng Wang
  • Treatment and prevention of cardiovascular disease and thrombosis
    Patent number: 9168233
    Abstract: Provided herein are compositions for the treatment and/or prevention of cardiovascular disease (CVD), and methods of application and use thereof. In particular, the present invention provides treatment and/or prevention of cardiovascular disease with compounds that inhibit the production of TMA in the gut, such as 3,3-dimethyl-1-butanol (DMB) or other compounds represented by Formula I or as shown in FIGS. 20-23.
    Type: Grant
    Filed: June 11, 2013
    Date of Patent: October 27, 2015
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Stanley L. Hazen, Bruce Levison, Zeneng Wang
  • TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE AND THROMBOSIS
    Publication number: 20130345171
    Abstract: Provided herein are compositions for the treatment and/or prevention of cardiovascular disease (CVD), and methods of application and use thereof. In particular, the present invention provides treatment and/or prevention of cardiovascular disease with compounds that inhibit the production of TMA in the gut, such as 3,3-dimethyl-1-butanol (DMB) or other compounds represented by Formula I or as shown in FIGS. 20-23.
    Type: Application
    Filed: June 11, 2013
    Publication date: December 26, 2013
    Inventors: Stanley L. Hazen, Bruce Levison, Zeneng Wang